Royal Bank Of Canada Summit Therapeutics Inc. Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
A detailed history of Royal Bank Of Canada transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 16,745 shares of SMMT stock, worth $336,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,745
Previous 11,457
46.16%
Holding current value
$336,574
Previous $47,000
176.6%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SMMT
# of Institutions
138Shares Held
64.4MCall Options Held
1.06MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$467 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$82.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$59.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.04B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...